ArticleInsights into imaging2026
Dual-energy CT pulmonary angiography using dual-flow mixture bolus tracking: potential for contrast medium and radiation exposure reduction.
Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
objectivesTo assess the feasibility and image quality of a bolus tracking protocol with dual-flow mixture for contrast medium volume and radiation dose reduction in dual-energy CT pulmonary angiography (CTPA). MATERIALS AND
methodsPatients with suspected pulmonary embolism (PE) were prospectively included and randomly divided into the dual low-dose or routine CTPA groups. Virtual monoenergetic imaging results at 40 keV for the dual low-dose CTPA group were compared to 100-kV polyenergetic CT images from the routine CTPA group. Attenuation, noise, contrast-to-noise ratio, and figure of merit were determined in multiple pulmonary arteries. Qualitative image quality and PE detection were independently rated by two radiologists.
resultsThe dual low-dose CTPA group showed a significantly higher attenuation in 40-keV virtual monoenergetic imaging (1027.0 ± 287.6 HU vs 391.8 ± 109.0 HU; p < 0.001) with a comparable median contrast-to-noise ratio (33.6 vs 41.0; p = 0.115) and superior figure of merit (711.4 vs 461.5; p = 0.006) in the pulmonary trunk in relation to that observed in the routine CTPA group. Superior vena cava artifacts were reduced (both p ≤ 0.002), while pulmonary branch visualization was preserved (p = 0.660 and 0.763). Effective radiation dose was lower in the dual low-dose CTPA group (1.61 mSv vs 3.62 mSv; p < 0.001), while PE diagnostic performance did not differ significantly between the two protocols.
conclusionThe dual-flow mixture bolus-tracking protocol showed technical feasibility for dual-energy CTPA, achieving substantial reductions in radiation exposure and contrast medium volume while maintaining diagnostically acceptable image quality. CRITICAL RELEVANCE STATEMENT: The dual-flow mixture bolus-tracking protocol with dual-energy CT maintained feasible image quality for PE assessment, facilitating contrast medium volume and radiation exposure reduction.
trial registrationNFEC, NFEC-2025-021, approved on January 10, 2025. KEY POINTS: Radiation exposure and substantial contrast medium doses during CTPA increased patient risks. Virtual monoenergetic imaging at 40 keV derived from dual-energy CT enhanced pulmonary vascular visualization. The dual-flow mixture technique with dual-energy CT reduced radiation dose and contrast medium volume.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.